This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada. Inari Medical is currently developing separate websites for our products tailored to these other global and regional markets.
UNDERSTANDING TRAVEL RISKS AND PREVENTING BLOOD CLOTS WHILE TRAVELING
The longer someone is immobile, the greater the risk of developing a blood clot becomes. Sitting still for long periods can cause the blood to pool and slow the flow of blood. Traveling for a long distance (four or more hours) combined with other risk factors can increase the risk for developing a clot.
These additional risk factors include:
Being over 65 years old
Inherited blood clotting disorder
Recent surgery or injury
Being overweight
Hormone replacement therapy
Mobility issue (for example, wearing a cast)
Being pregnant or having given birth in the last 3 months
Birth control pills, patch, or ring
History of previous deep vein thrombosis (DVT) or pulmonary embolism (PE)
Talk to your doctor for other travel recommendations if you have had a DVT or PE in the past, are recovering from surgery, are taking blood thinners, or have other medical conditions that put you at risk for a blood clot.
WHERE CAN I LEARN MORE ABOUT TRAVELING AND BLOOD CLOTS?
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment.
Sources:
1. Fennerty, A. Venous thromboembolic disease and cancer. Postgraduate Medical Journal 2006 Oct; 82:642-648.
2. CDC: https://www.cdc.gov/ncbddd/dvt/materials/cancer-and-blood-clots.html
Indications for Use:
The FlowTriever® system is indicated for (1) the non-surgical removal of emboli and thrombi from blood vessels and (2) injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. The FlowTriever system is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism. Triever catheters are intended for use in treating clot in transit in the right atrium but not in conjunction with FlowTriever catheters. The FlowTriever2® catheter is intended for use in the peripheral vasculature. The FlowSaver® blood return system is used with Triever catheters for autologous blood transfusion. The ClotTriever® Thrombectomy System is indicated for: (1) The non-surgical removal of thrombi and emboli from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The ClotTriever Thrombectomy System is intended for use in the peripheral vasculature including deep vein thrombosis (DVT). The ClotTriever Sheaths are indicated for use as a conduit for the insertion of endovascular devices into the vasculature while minimizing blood loss associated with such insertions.